01 1Biocon
01 1POSACONAZOLE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-25
Pay. Date : 2022-02-07
DMF Number : 36688
Submission : 2022-02-01
Status : Active
Type : II
20
Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is POSACONAZOLE, with a corresponding US DMF Number 36688.
Remarkably, this DMF maintains an Active status since its submission on February 01, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 25, 2022, and payment made on February 07, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
